An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis

NCT04130997 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1100

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis (RMS)

Interventions

BIOLOGICAL: Ublituximab

Sponsor

TG Therapeutics, Inc.